Taylor Eric
Institute of Psychiatry, Psychology and NeuroScience, King's College London, UK.
Z Kinder Jugendpsychiatr Psychother. 2019 Nov;47(6):542-546. doi: 10.1024/1422-4917/a000664. Epub 2019 Apr 23.
This review starts from the finding that there is strong persistence of ADHD problems into adult life, despite the availability of effective treatment with stimulants and other drugs. Short-term trials in adults reveal that those drugs can still be efficacious in adults. Pharmacoepidemiology studies, on the other hand, clearly show that most young people discontinue medication during adolescence. Neuropharmacology research suggests a waning of stimulant effects after a few years. Longitudinal studies are scarce but provide some evidence that prognosis is often determined by factors other than the core symptoms of inattentiveness and impulsive overactivity. The implications for clinical practice are discussed. Continuing care, especially during the follow-up after initial therapy, needs further development.
尽管有兴奋剂和其他药物的有效治疗,但多动症问题在成年后仍有很强的持续性。针对成年人的短期试验表明,这些药物在成年人中仍然有效。另一方面,药物流行病学研究清楚地表明,大多数年轻人在青春期会停止用药。神经药理学研究表明,几年后兴奋剂的效果会逐渐减弱。纵向研究很少,但提供了一些证据,表明预后往往由注意力不集中和冲动多动等核心症状以外的因素决定。文中讨论了对临床实践的影响。持续护理,尤其是在初始治疗后的随访期间,需要进一步发展。